A successful management with electroconvulsive therapy of neuroleptic malignant syndrome due to amisulpride

被引:0
|
作者
Karayagmurlu, Ali [1 ]
Karayagmurlu, Elif [2 ]
Ustundag, Mehmet Fatih [3 ]
Yazla, Ece [4 ]
机构
[1] Gaziantep Child State Hosp, Dept Child & Adolescent Psychiat, Gaziantep, Turkey
[2] Gaziantep Univ, Dept Psychiat, Fac Med, Gaziantep, Turkey
[3] Erenkoy Training & Res Hosp Psychiat & Neurol Dis, Dept Psychiat, Istanbul, Turkey
[4] Hitit Univ, Fac Med, Dept Psychiat, Corum, Turkey
来源
ELECTRONIC JOURNAL OF GENERAL MEDICINE | 2018年 / 15卷 / 03期
关键词
amisulpride; atypical antipsychotics; neuroleptic malignant syndrome; electroconvulsive therapy;
D O I
10.29333/ejgm/83617
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neuroleptic malignant syndrome is a severe complication that mainly occurs based on neuroleptic drug treatment and characterized with some autonomic symptoms, altered mental state, hyperthermia and muscle rigidity. Amisulpride is a unique atypical antipsychotic that selectively blocks D2 and D3 receptors presynaptically in the frontal cortex and atypical antipsychotics are rarely caused neuroleptic malignant syndrome (NMS). This study examine a 20-years old male with the diagnosis of acute psychotic disorder occurred amisulpride-induced NMS and successfully treated with Electroconvulsive Therapy (ECT). We decided to present that case because of the fact that there is only limited number of amisulpride-induced NMS cases reported in the literature.
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Amisulpride-induced neuroleptic malignant syndrome
    Abay, Ercan
    Kose, Rugul
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2007, 19 (04) : 488 - 489
  • [22] Propofol-Remifentanil Combination for Management of Electroconvulsive Therapy in a Patient with Neuroleptic Malignant Syndrome
    Arasteh, Modabber
    Shami, Shoaleh
    Nasseri, Karim
    CASE REPORTS IN MEDICINE, 2012, 2012
  • [23] Amisulpride-induced neuroleptic malignant syndrome
    Knific, Jana
    Kogoj, Ales
    ACTA NEUROPSYCHIATRICA, 2008, 20 (02): : 108 - 109
  • [24] Drug resistant neuroleptic malignant syndrome and the role of electroconvulsive therapy
    Hashim, Husnain
    Zeb-un-Nisa
    Alrukn, Suhail Abdulla Mohammad
    Al Madani, Abubaker Abdul Rahman Shaffi
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2014, 64 (04) : 471 - 473
  • [26] Treatment of Neuroleptic Malignant Syndrome with Electroconvulsive Therapy in an Adolescent with Psychosis
    Tanidir, Canan
    Aksoy, Sena
    Canbek, Ozge
    Aras, Gizem Funda
    Kilicoglu, Ali Guven
    Erdogan, Ayten
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2016, 26 (02) : 179 - 180
  • [27] Electroconvulsive therapy in a adolescent with neuroleptic malignant syndrome: case report
    Araujo, Manuela
    Freitas, Daniela
    Queiros, Otilia
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2013, 22 : S306 - S306
  • [28] Neuroleptic malignant syndrome: a case responding to electroconvulsive therapy plus bupropion
    Foguet-Boreu, Quinti
    Coll-Negre, Montse
    Serra-Millas, Montse
    Cavalleria-Verdaguer, Miquel
    CLINICS AND PRACTICE, 2018, 8 (01) : 19 - 20
  • [29] Electroconvulsive therapy for a patient with lethal catatonia-neuroleptic malignant syndrome
    Chang, V. C.
    Hardesty, D.
    Pietro, M.
    MOVEMENT DISORDERS, 2007, 22 : S215 - S215
  • [30] Electroconvulsive therapy using rocuronium and sugammadex in patient with neuroleptic malignant syndrome
    Saeki, N.
    Kwon, R.
    Migita, T.
    Fukuda, H.
    Hamada, H.
    Kawamoto, M.
    ANAESTHESIA AND INTENSIVE CARE, 2011, 39 (04) : 762 - 763